Last updated July 19th 2017

Rapid medical logoJuly 17, 2017 | Rapid Medical, an Israeli company that develops neurovascular interventional devices, raised $9 million in a Series B financing round. Founded in 2008 by CEO Ronen Eckhouse and Chairman of the Board Shimon Eckhouse, Rapid Medical is seeking to further commercialize TIGERTRIEVER Revascularization Device and the COMANECI Adjustable Remodeling Mesh, products which provide prevention and minimally invasive stroke treatment. Israel’s BRM and China’s Shanghai-Israel Investment Fund led the round, while Winnovation and Gefen Capital participated. [Photo: Courtesy]